Antidepressant Market Will Remain Flat In Face Of Adult Suicidality Concerns, Forest Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The impact of media attention on the adult suicide issue will be “hard to predict,” President & COO Goodman says. Forest expects FDA action on a Namenda supplemental NDA for mild-to-moderate Alzheimer’s in the next few weeks.